BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 28130592)

  • 21. Assessing the impact of a sacral resection on morbidity and survival after extended radical surgery for locally recurrent rectal cancer.
    Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD
    Ann Surg; 2013 Dec; 258(6):1007-13. PubMed ID: 23364701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgery and pre-operative irradiation for locally advanced or recurrent rectal cancer in patients over 75 years of age.
    Larsen SG; Wiig JN; Tretli S; Giercksky KE
    Colorectal Dis; 2006 Mar; 8(3):177-85. PubMed ID: 16466556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abdominosacral resection for primary irresectable and locally recurrent rectal cancer.
    Mannaerts GH; Rutten HJ; Martijn H; Groen GJ; Hanssens PE; Wiggers T
    Dis Colon Rectum; 2001 Jun; 44(6):806-14. PubMed ID: 11391140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benchmarking trial between France and Australia comparing management of primary rectal cancer beyond TME and locally recurrent rectal cancer (PelviCare Trial): rationale and design.
    Denost Q; Saillour F; Masya L; Martinaud HM; Guillon S; Kret M; Rullier E; Quintard B; Solomon M
    BMC Cancer; 2016 Apr; 16():262. PubMed ID: 27044252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
    Tulchinsky H; Shmueli E; Figer A; Klausner JM; Rabau M
    Ann Surg Oncol; 2008 Oct; 15(10):2661-7. PubMed ID: 18389322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Use of Re-irradiation in Locally Recurrent, Non-metastatic Rectal Cancer.
    Susko M; Lee J; Salama J; Thomas S; Uronis H; Hsu D; Migaly J; Willett C; Czito B; Palta M
    Ann Surg Oncol; 2016 Oct; 23(11):3609-3615. PubMed ID: 27169769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transperineal retropubic approach in total pelvic exenteration for advanced and recurrent colorectal and anal cancer involving the penile base: technique and outcomes.
    Mehta AM; Hellawell G; Burling D; Littler S; Antoniou A; Jenkins JT
    Tech Coloproctol; 2018 Sep; 22(9):663-671. PubMed ID: 30306276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of pelvic exenteration for locally advanced primary rectal cancer: Overall survival and quality of life.
    Quyn AJ; Austin KK; Young JM; Badgery-Parker T; Masya LM; Roberts R; Solomon MJ
    Eur J Surg Oncol; 2016 Jun; 42(6):823-8. PubMed ID: 26947962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Total pelvic exenteration for locally advanced and locally recurrent rectal cancer in the elderly.
    Hagemans JAW; Rothbarth J; Kirkels WJ; Boormans JL; van Meerten E; Nuyttens JJME; Madsen EVE; Verhoef C; Burger JWA
    Eur J Surg Oncol; 2018 Oct; 44(10):1548-1554. PubMed ID: 30075979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer.
    Yamada K; Ishizawa T; Niwa K; Chuman Y; Aikou T
    Dis Colon Rectum; 2002 Aug; 45(8):1078-84. PubMed ID: 12195193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Feasibility and Efficacy of Laparoscopic Extended Total Mesorectal Excision for Locally Advanced Lower Rectal Cancer.
    Nonaka T; Fukuda A; Maekawa K; Nagayoshi S; Tokunaga T; Takatsuki M; Kitajima T; Taniguchi K; Fujioka H
    In Vivo; 2018; 32(3):643-648. PubMed ID: 29695572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgery for locally recurrent rectal cancer.
    Boyle KM; Sagar PM; Chalmers AG; Sebag-Montefiore D; Cairns A; Eardley I
    Dis Colon Rectum; 2005 May; 48(5):929-37. PubMed ID: 15785880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Surgery on Health-Related Quality of Life of Patients With Locally Recurrent Rectal Cancer.
    Pellino G; Sciaudone G; Candilio G; Selvaggi F
    Dis Colon Rectum; 2015 Aug; 58(8):753-61. PubMed ID: 26163954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High subcortical sacrectomy: a novel approach to facilitate complete resection of locally advanced and recurrent rectal cancer with high (S1-S2) sacral extension.
    Shaikh I; Holloway I; Aston W; Littler S; Burling D; Antoniou A; Jenkins JT;
    Colorectal Dis; 2016 Apr; 18(4):386-92. PubMed ID: 26638828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aggressive surgical treatment with bony pelvic resection for locally recurrent rectal cancer.
    Uehara K; Ito Z; Yoshino Y; Arimoto A; Kato T; Nakamura H; Imagama S; Nishida Y; Nagino M
    Eur J Surg Oncol; 2015 Mar; 41(3):413-20. PubMed ID: 25477268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Local tumor control and (disease-free) survival after surgery with pre- and intraoperative radiotherapy for primary non-resectable rectal carcinoma and local recurrence].
    Mannaerts GH; Martijn H; Rutten HJ; Hanssens PE; Wiggers T
    Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1460-6. PubMed ID: 11503316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies.
    Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD; Austin KK
    Dis Colon Rectum; 2014 Oct; 57(10):1153-61. PubMed ID: 25203370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of survival following pelvic exenteration for primary rectal cancer.
    Radwan RW; Jones HG; Rawat N; Davies M; Evans MD; Harris DA; Beynon J;
    Br J Surg; 2015 Sep; 102(10):1278-84. PubMed ID: 26095525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sacral resection for recurrent rectal cancer: analysis of morbidity and treatment results.
    Melton GB; Paty PB; Boland PJ; Healey JH; Savatta SG; Casas-Ganem JE; Guillem JG; Weiser MR; Cohen AM; Minsky BD; Wong WD; Temple LK
    Dis Colon Rectum; 2006 Aug; 49(8):1099-107. PubMed ID: 16779712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.